PillRx only · Tablet · Oral
Dapagliflozin
Dapagliflozin
6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US12 NDCs
6 active makers
6 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.195
Latest avg · Jun 3, 2026
-98%
Since Apr 15, 2026
6
Active US suppliers
50%
Top-2 supplier share*
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it6 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Macleods Pharmaceuticals Limited | unknown | 6 | SUPPLYING |
| Florida Pharmaceutical Products, LLC | unknown | 6 | SUPPLYING |
| Zydus Lifesciences Limited | unknown | 4 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | unknown | 4 | SUPPLYING |
| Ajanta Pharma USA Inc. | unknown | 2 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | unknown | 2 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.